[Treatment of secondary infections in symptomatic HIV-infections in childhood]. 1993

V Wahn, and B H Belohradsky, and S Enenkel-Stoodt, and I Grosch-Wörner, and P Höger, and M Langhof, and R Müller, and G Notheis, and C Schultheiss, and V Schuster
Universitäts-Kinderkliniken Düsseldorf.

Treatment of secondary infections in HIV infected children represents a problem of increasing importance in several children's hospitals. As it is unlikely that the AIDS-problem will be solved by itself within the next years it seems reasonable to summarize our current knowledge about opportunistic infections in order to establish standards for therapy. We will mainly focus on microorganisms endemic in Germany.

UI MeSH Term Description Entries
D002423 Cause of Death Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint. Causes of Death,Death Cause,Death Causes
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival
D017088 AIDS-Related Opportunistic Infections Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus. HIV-Related Opportunistic Infections,Opportunistic Infections, AIDS-Related,Opportunistic Infections, HIV-Related,AIDS Related Opportunistic Infections,AIDS-Related Opportunistic Infection,HIV Related Opportunistic Infections,HIV-Related Opportunistic Infection,Infection, HIV-Related Opportunistic,Infections, HIV-Related Opportunistic,Opportunistic Infection, AIDS-Related,Opportunistic Infection, HIV-Related,Opportunistic Infections, AIDS Related,Opportunistic Infections, HIV Related

Related Publications

V Wahn, and B H Belohradsky, and S Enenkel-Stoodt, and I Grosch-Wörner, and P Höger, and M Langhof, and R Müller, and G Notheis, and C Schultheiss, and V Schuster
December 1990, Tijdschrift voor kindergeneeskunde,
V Wahn, and B H Belohradsky, and S Enenkel-Stoodt, and I Grosch-Wörner, and P Höger, and M Langhof, and R Müller, and G Notheis, and C Schultheiss, and V Schuster
March 1975, Acta paediatrica Scandinavica,
V Wahn, and B H Belohradsky, and S Enenkel-Stoodt, and I Grosch-Wörner, and P Höger, and M Langhof, and R Müller, and G Notheis, and C Schultheiss, and V Schuster
May 2001, The Journal of infection,
V Wahn, and B H Belohradsky, and S Enenkel-Stoodt, and I Grosch-Wörner, and P Höger, and M Langhof, and R Müller, and G Notheis, and C Schultheiss, and V Schuster
August 1959, Industrial medicine & surgery,
V Wahn, and B H Belohradsky, and S Enenkel-Stoodt, and I Grosch-Wörner, and P Höger, and M Langhof, and R Müller, and G Notheis, and C Schultheiss, and V Schuster
January 1969, Godisen zbornik na Medicinskiot fakultet vo Skopje,
V Wahn, and B H Belohradsky, and S Enenkel-Stoodt, and I Grosch-Wörner, and P Höger, and M Langhof, and R Müller, and G Notheis, and C Schultheiss, and V Schuster
January 1996, Duodecim; laaketieteellinen aikakauskirja,
V Wahn, and B H Belohradsky, and S Enenkel-Stoodt, and I Grosch-Wörner, and P Höger, and M Langhof, and R Müller, and G Notheis, and C Schultheiss, and V Schuster
April 1964, Monatsschrift fur Kinderheilkunde,
V Wahn, and B H Belohradsky, and S Enenkel-Stoodt, and I Grosch-Wörner, and P Höger, and M Langhof, and R Müller, and G Notheis, and C Schultheiss, and V Schuster
September 1974, Arzneimittel-Forschung,
V Wahn, and B H Belohradsky, and S Enenkel-Stoodt, and I Grosch-Wörner, and P Höger, and M Langhof, and R Müller, and G Notheis, and C Schultheiss, and V Schuster
February 2001, Revista clinica espanola,
V Wahn, and B H Belohradsky, and S Enenkel-Stoodt, and I Grosch-Wörner, and P Höger, and M Langhof, and R Müller, and G Notheis, and C Schultheiss, and V Schuster
April 1983, Pediatric clinics of North America,
Copied contents to your clipboard!